HEXO Corp. (HEXO)
(Delayed Data from AMEX)
$7.73 USD
+0.27 (3.62%)
Updated May 3, 2019 04:00 PM ET
After-Market: $7.72 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.73 USD
+0.27 (3.62%)
Updated May 3, 2019 04:00 PM ET
After-Market: $7.72 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Marijuana Stocks & ETFs: What Investors Need to Know
by Neena Mishra
Here is what investors need to know about cannabis investing and the first actively managed pot ETF.
HEXO (HEXO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed the most recent trading day at $7.15, moving -1.11% from the previous trading session.
What's in Store for Aurora Cannabis (ACB) in Q3 Earnings?
by Zacks Equity Research
Continued execution of consumer and medical strategies, launch of new products and strong international footprint are likely to aid Aurora Cannabis (ACB) in Q3.
Aurora Cannabis (ACB) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Aurora Cannabis (ACB) likely to gain from solid prospects in the Canadian and international consumer markets in fiscal Q3.
HEXO (HEXO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed the most recent trading day at $7.53, moving +0.67% from the previous trading session.
Inogen (INGN) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Inogen's (INGN) first-quarter 2019 results are expected to get a boost from product launches.
Can BD Medical Drive Becton, Dickinson's (BDX) Q2 Earnings?
by Zacks Equity Research
Becton, Dickinson (BDX) expects BD Medical to drive fiscal Q2 results; foreign exchange headwinds persist.
Apyx Medical (APYX) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Apyx Medical (APYX) likely to gain from J-plasma technology in Q1; margins under pressure.
HEXO (HEXO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed the most recent trading day at $7.83, moving +0.06% from the previous trading session.
HEXO (HEXO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed at $7.15 in the latest trading session, marking a +0.28% move from the prior day.
HEXO (HEXO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed at $6.76 in the latest trading session, marking a +1.65% move from the prior day.
HEXO Catches Eye: Stock Jumps 6.6%
by Zacks Equity Research
HEXO saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Zacks.com featured expert Kevin Matras highlights: Balchem, Methode Electronics, Chemed, Ubiquiti Networks and HEXO
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Balchem, Methode Electronics, Chemed, Ubiquiti Networks and HEXO
5 Stocks in Focus on New Analysts Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
Pot Stocks are on a High: Play These Marijuana ETFs
by Sanghamitra Saha
As marijuana stocks soar into the new year, which ETFs should investors consider?